About
About

The Leader in Autologous Fibroblast Therapies

At the forefront of personalized biologics 

Fibrocell, a cell and gene therapy company, is focused on diseases affecting the skin and connective tissue. Our approach to personalized biologics is distinctive based on our proprietary autologous fibroblast technology. By extracting fibroblast cells from a patient’s own skin, we create localized gene therapies that are compatible with the unique biology of each patient and have the potential to address the underlying cause of disease.

 

Our Vision

To be a leader in creating personalized biologics that have the potential to transform the lives of patients and the future of medicine.

 

Our Mission

We are dedicated to developing transformational autologous cell-based therapies that have the potential to offer hope and relief to patients and families suffering from rare genetic diseases affecting the skin and connective tissue.


collage-row-1

collage-row-2

about-fibrocell-collage-3

about-fibrocell-collage-4


Top row, left and right photos: Courtesy of debra–The Dystrophic Epidermolysis Bullosa Research Association of America. Used with permission.
Third row, center photo: Courtesy of EB Research Partnership and P. Martinez. Credit: Hal Horowitz Photography.
Bottom row, left photo: Courtesy of debra–The Dystrophic Epidermolysis Bullosa Research Association of America. Used with permission.
Bottom row, right photo: Courtesy of EB Research Partnership and P. Martinez. Credit: Hal Horowitz Photography.